John D. Gaffen
- Rheumatology top 10%
- Pharmacology top 10%
- Molecular Biology
- Cancer Research
- Surgery
- Co-authors
- A. B. BennettMichael T. BaylissRoger M. MasonJ. FlannellyJayesh DudhiaM.G. ChambersI A TavaresI F Stamford
- Topics
- Osteoarthritis Treatment and Mechanisms (4 papers)Inflammatory mediators and NSAID effects (4 papers)Cell Adhesion Molecules Research (3 papers)
- Cited by
- RheumatologyEquinePharmacology
- Partner nations
- United KingdomDenmarkCanada
In The Last Decade
John D. Gaffen
17 papers receiving 298 citations
Peers
Comparison fields: 5 of 63
- Rheumatology 122
- Pharmacology 94
- Molecular Biology 83
- Cancer Research 52
- Surgery 51
Countries citing papers authored by John D. Gaffen
This map shows the geographic impact of John D. Gaffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Gaffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Gaffen more than expected).
Fields of papers citing papers by John D. Gaffen
This network shows the impact of papers produced by John D. Gaffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Gaffen. The network helps show where John D. Gaffen may publish in the future.
Co-authorship network of co-authors of John D. Gaffen
This figure shows the co-authorship network connecting the top 25 collaborators of John D. Gaffen. A scholar is included among the top collaborators of John D. Gaffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Gaffen. John D. Gaffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 109 | |
| 3 | 8 | |
| 4 | 40 | |
| 5 | OSTEOARTHRITIS and CARTILAGE Elevated aggrecan mRNA in early murine osteoarthritis | 1 |
| 6 | 19 | |
| 7 | 7 | |
| 8 | 2 | |
| 9 | 4 | |
| 10 | 12 | |
| 11 | 10 | |
| 12 | 21 | |
| 13 | Indomethacin increases the cytotoxicity of methotrexate in vitro and in vivo. | 3 |
| 14 | 10 | |
| 15 | 10 | |
| 16 | 20 | |
| 17 | In vitro biological effects of glass fibers. | 21 |
About John D. Gaffen
John D. Gaffen is a scholar working on Equine, Immunology and Allergy and Toxicology, having authored 17 papers that have together received 317 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Rheumatology (122 citations), Equine (10 citations) and Pharmacology (94 citations). John D. Gaffen has collaborated with scholars based in United Kingdom, Denmark and Canada. Frequent co-authors include A. B. Bennett, Michael T. Bayliss, Roger M. Mason, J. Flannelly, Jayesh Dudhia, M.G. Chambers, I A Tavares, I F Stamford, Stacia Kargman and P K Weech. Their work appears in journals such as Analytical Biochemistry, Gut and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.